Company intelligence / Profile preview

CytaCoat

Solna, Stockholm, Swedencytacoat.com ↗

Ownership: Private
Employees: ~9
Development stage: Preclinical

Overview

CytaCoat has developed a unique antimicrobial coating technology for medical devices to prevent healthcare-associated infections. The company is currently active in the urinary catheter and wound care market segments, developing clinical evidence to support market entry.

Therapeutic areas: Infectious Diseases
Modalities: Anti-foulinganti-biofilm coating technology
Industry: Consumable Medical Devices

Partnerships

Absorbest (for superabsorbent advanced wound care dressings)

Beyond the preview

Go deeper on CytaCoat.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CytaCoat.

Explore the full profile